IONTAS, Teva announce new antibody optimisation agreement
Teva recently halted its Ajovy clinical development.
Read More
Tag: biotherapeutics
CR UK invests £14m in London cancer biotherapeutics hub
Cancer Research UK is investing some £14 million into transforming the city of London into a “world-leading hub for cancer biotherapeutics”.
Read More
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
